Overview
AOD-9604 is a peptide fragment derived from the tail end of human growth hormone, studied for effects on fat metabolism without the broader growth-promoting actions of full GH.
How It's Thought to Work
Research suggests it may influence lipolysis (fat breakdown) and fat oxidation, reportedly without significantly affecting IGF-1 or blood sugar in the way GH can.
What the Research Says
Early-phase human trials for obesity did not produce the weight-loss results hoped for; much of the continued interest is preclinical or anecdotal.
Regulatory & Legal Status
Not an FDA-approved weight-loss drug. Has appeared as an ingredient in some regulated contexts, but injectable 'research chemical' forms are unapproved.
Safety Considerations
Limited human efficacy and safety data for consumer use; unregulated product quality. Consult a qualified clinician.